Skip to main content
. 2023 Mar 28;15(7):2021. doi: 10.3390/cancers15072021

Table 3.

Prognostic analysis of ORR (a) and DCR (b) in patients who received immune checkpoint inhibitor therapy.

(a) Overall Response Rate
Univariate
Odds Ratio 95% CI p-Value
Age (<70 or >70) 0.997 0.458–2.17 0.9940
BMI (Cutoff: 20) 0.527 0.211–1.32 0.1720
Alb (Cutoff:4.1) 0.676 0.289–1.58 0.3650
CRP (Cutoff:0.89) 1.35 0.582–3.11 0.4880
PLR (Cutoff: 397) 0.736 0.337–1.61 0.4410
NLR (Cutoff: 6.7) 0.732 0.336–1.6 0.4330
LMR (cutoff: 1.88) 0.892 0.386–2.06 0.7890
SII (Cutoff: 107.5) 1.44 0.518–4.02 0.4830
CAR (Cutoff: 0.14) 0.623 0.272–1.43 0.2640
CONUT (Cutoff: 3) 0.78 0.26–2.34 0.6570
PNI (Cutoff: 37.7) 1.72 0.781–3.78 0.1780
PI (Cutoff: 0) 2.01 0.817–4.92 0.1290
GPS (Cutoff: 0) 0.627 0.277–1.42 0.2630
(b) Disease control rate
Univariate Multivariate
Odds ratio 95% CI p-value Odds ratio 95% CI p-value
Age (<70 or >70) 0.452 0.179–1.14 0.0925 0.391 0.145–1.06 0.651
BMI (Cutoff: 20) 0.393 0.149–1.04 0.0598 1.82 0.682–4.86 0.232
Alb (Cutoff:4.1) 0.487 0.192–1.24 0.1300
CRP (Cutoff:0.89) 2.4 0.952–6.05 0.0635
PLR (Cutoff: 397) 0.365 0.144–0.923 0.0332 0.397 0.117–1.41 0.157
NLR (Cutoff: 6.7) 0.626 0.255–1.54 0.3070
LMR (cutoff: 1.88) 0.521 0.206–1.31 0.1670
SII (Cutoff: 107.5) 2.93 1.01–8.52 0.0478 0.613 0.186–2.02 0.420
CAR (Cutoff: 0.14) 0.382 0.152–0.957 0.0399 0.619 0221–1.74 0.360
CONUT (Cutoff: 3) 0.448 0.142–1.41 0.1700
PNI (Cutoff: 37.7) 2.09 0.847–5.16 0.1100
PI (Cutoff: 0) 2.54 0.788–8.18 0.1190
GPS (Cutoff: 0) 0.434 0.174–1.08 0.0726

ORR, objective response rate; DCR, disease response rate; PLR, platelet to lymphocyte ratio; NLR, neutrophil to lymphocyte ratio; LMR, lymphocyte to monocyte ratio; SII, systemic immune-inflammation index; CAR, CRP to Alb ratio; CONUT, controlling nutritional status; PNI, prognostic nutrition index; PI, predictive index; GPS, Glasgow prognostic score; BMI, body mass index; Alb, albumin; CRP, C-reactive protein. Bold indicates statistically significant p-values.